Vaccines are entering a new era and recently we hosted a virtual event to share insights on market trends, challenges, and potential solutions regarding the future of vaccine manufacturing.

by Carole Inglevert | September 4, 2023

vaccines_new_era

In this On-Demand version of the presentations, key opinion leaders from

Merck KGaA, Darmstadt, Germany
MilliporeSigma
, Hileman Laboratories Singapore, Baylor College of Medicine or Biofarma, provide a fascinating story of the behind of the scenes development of the recent pandemic and how long-term collaboration to optimize a neglected tropical disease vaccine platform transformed into the COVID-19 vaccine candidates.

Additionally, you will learn about:

  • Technical transfer in vaccine manufacturing –  including real world stories on bringing platforms to products
  • Trends and costs in vaccine manufacturing – in both traditional and novel platforms.
  • Applying Quality-by-Design concepts to vaccine manufacturing – finally, we will share information on how Quality by Design (QbD) is applied in vaccine manufacturing, including the principles and application. We will include case studies with a special feature of TFF technologies. Last, but not least, we will discuss the scale-up consideration using the QbD concept.

Be sure to register to view this valuable 2 1/2 hour lecture series

[molongui_author_box]

Related Posts

Starting your journey into manufacturing – choosing a cell line development provider

One of the biggest decisions which any company developing biological medicines makes is to move forward to the manufacture of their product. …

Covid-19 Impact on Bioprocessing: PART 1 Accelerating Trends

The views and opinions expressed in this blog / article are those of the authors and do not…

Covid-19 Impact on Bioprocessing: PART 2 Fears to Be Addressed due to Covid-19

The views and opinions expressed in this blog / article are those of the authors and do not…

Covid-19 Impact on Bioprocessing: PART 3 Long-term Changes Resulting from the Pandemic

The views and opinions expressed in this blog / article are those of the authors and do not…

Scroll to Top